Ixifi

infliximab biosimilar · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ixifi, covering 2025-06-19 to 2025-06-19. Get the full timeline:

Most recent: Clinical Trial Update: Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)